Gurevich, E.; Hayoz, M.; Aebi, Y.; Largiadèr, C.R.; Mansouri Taleghani, B.; Bacher, U.; Pabst, T.
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML. Cancers 2022, 14, 1024.
https://doi.org/10.3390/cancers14041024
AMA Style
Gurevich E, Hayoz M, Aebi Y, Largiadèr CR, Mansouri Taleghani B, Bacher U, Pabst T.
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML. Cancers. 2022; 14(4):1024.
https://doi.org/10.3390/cancers14041024
Chicago/Turabian Style
Gurevich, Ekaterina, Michael Hayoz, Yolanda Aebi, Carlo R. Largiadèr, Behrouz Mansouri Taleghani, Ulrike Bacher, and Thomas Pabst.
2022. "Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML" Cancers 14, no. 4: 1024.
https://doi.org/10.3390/cancers14041024
APA Style
Gurevich, E., Hayoz, M., Aebi, Y., Largiadèr, C. R., Mansouri Taleghani, B., Bacher, U., & Pabst, T.
(2022). Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML. Cancers, 14(4), 1024.
https://doi.org/10.3390/cancers14041024